Search results
Exact Sciences stock drops as Guardant Health test supported by FDA panel By Investing.com
Investing.com· 10 hours agoFood and Drug Administration's (FDA) Medical Devices Advisory Committee has strongly recommended FDA...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients By Reuters
Investing.com· 4 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
Why is the FDA looking to ban this ingredient found in most sodas? - Dexerto
Dexerto· 11 hours agoA common ingredient used in sodas like Mountain Dew and Gatorade in the past has been flagged by the...
FDA grants IND clearance for Abdera’s Phase I cancer therapy trial
Clinical Trials Arena via Yahoo Finance· 13 hours agoThe US Food and Drug Administration (FDA) has granted clearance for Abdera Therapeutics'...
Apricot Power refuses to recall toxic apricot seeds
Consumer Affairs· 3 hours agoFood and Drug Administration found they were toxic. Analysis of three samples showed seeds contained high levels of the toxic compound amygdalin, which...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks via Yahoo Finance· 1 day agoCartesian Therapeutics, Inc. RNAC announced that the FDA has granted the Regenerative Medicine...
Guardant Health Stock Jumps 12%
Barrons.com· 8 hours agoThe FDA is expected to decide whether or not to approve the blood test, Shield, later this year.Read the full article
Novavax awaits FDA decision on whether its next COVID shot can be offered in US By Reuters
Investing.com· 5 hours agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European...
Exact Sciences stock drops as Guardant Health test supported by FDA panel
Investing.com· 20 hours agoExact Sciences stock drops as Guardant Health test supported by FDA panel
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
AOL· 4 hours agoThe Food and Drug Administration's panel voted 7-to-4 against the use of the weekly basal insulin icodec saying its benefits do not outweigh the risks when used in adult patients with type 1 ...